Quick Takeaways
- Flaherty Keith T. has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Flaherty Keith T.
- Location
- Boston, MA
- Signature
- /s/ James P. Reilly, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Flaherty Keith T. and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Kinnate Biopharma Inc. ($0).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Flaherty Keith T.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc. | Director | $0 | 03 Apr 2024 | ||
| CMPI | Checkmate Pharmaceuticals, Inc. | Director | 31 May 2022 | |||
| CLVS | Clovis Oncology, Inc. | Director | 10 Jun 2021 |
Insider Transactions Reported by Flaherty Keith T.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.